0001683131
false
--06-30
0001683131
2023-09-01
2023-09-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM
8-K
________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September
1, 2023
_______________________________
FORZA
INNOVATIONS INC.
(Exact
name of registrant as specified in its charter)
_______________________________
| Wyoming |
000-56131 |
30-0852686 |
| (State
or Other Jurisdiction |
(Commission |
(I.R.S.
Employer |
| of
Incorporation) |
File
Number) |
Identification
No.) |
406
9th Avenue, Suite
310
San
Diego, California
92101
Tel:
(619)
324-7388
(Address
and telephone number of principal executive offices)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
☐
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
| |
|
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
September 1, 2023, Forza Innovations Inc. (the “Company”) filed a Certificate of Amendment with the Secretary of State of
the State of Wyoming to cancel its previously announced reverse stock split.
Item
7.01 Regulation FD Disclosure
The
information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.
Attached
hereto as Exhibit 99.1 and incorporated by reference herein is a press release of Forza Innovations Inc. (the “Company”)
titled “Navigating Challenges: Forza Innovations Inc. Shares Insights on Debt and Growth”.
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
FORZA
INNOVATIONS INC. |
| |
|
|
| Date:
September 12, 2023 |
By: |
/s/ Johnny
Forzani |
|
|
Johnny
Forzani, President & C.E.O. |
Navigating
Challenges: Forza Innovations Inc. Shares Insights on Debt and Growth
FORZ
delivers a crucial update on its corporate trajectory and strategic determinations in response to the challenges posed by convertible
debt
Forza Innovations
Inc (OTCMKTS:FORZ)
CHARLOTTE,
NC, USA, September 12, 2023/EINPresswire.com/ -- Forza Innovations Inc. (OTC PINK:FORZ) provides an important update on its corporate
direction and strategic decisions in response to the challenges faced with convertible debt. Convertible debt can be daunting for pre-revenue
tech companies. While some may perceive the risks, the reality is often a balance between securing necessary funds and safeguarding the
future. "In many cases, the only available path for CEOs is the complex landscape of convertible lending," states Johnny Forzani,
President of Forza.
The company had previously considered a reverse split as a potential solution. However, after extensive research and understanding the
implications, particularly concerning shareholder value, the decision has been made to not move forward with the reverse.
**A Positive Outlook Ahead**
With the expedited patent filed in March for our groundbreaking technology, Forza remains optimistic about the upcoming year. The USPTO
has provided assurances of an approval notice within a calendar year. "We're confident that our IP will be granted," Forzani
adds. "Our flagship WarmUp product, once patented and FDA-approved to treat Chronic back pain, has the potential to revolutionize
the market and usher in new avenues for growth. With design, testing, and mass production readiness achieved, securing the patent will
undoubtedly open more favorable funding possibilities."
**Reflecting on Past Challenges and Looking to the Future**
Balancing the needs of two startups, especially on the OTC PK where funding options are severely limited and the associated costs of
maintaining fully reported company status, also presents challenges. The margin for error is narrow, and any setbacks can have profound
implications. Forzani reflects, "True learning often comes from firsthand experiences, understanding past errors, and applying those
lessons to shape a brighter future."
The year presented its fair share of challenges, but the goals remains undeterred. "We faced significant trials this year, but our
journey is far from over. We're committed to navigating the debt and investing our continuous efforts to position Forza in a stronger,
healthier place for the future," Forzani concludes.
Johnny
Forzani
Forza Innovations Inc
johnny@forzinnovations.com
